Le SIDA en Afrique subsaharienne (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
***** Acces problem to record *****\

Identifieur interne : 001D36 ( Pmc/Corpus ); précédent : 001D359; suivant : 001D370 ***** probable Xml problem with record *****

Links to Exploration step


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The role of harm reduction in controlling HIV among injecting drug users</title>
<author>
<name sortKey="Wodak, Alex" sort="Wodak, Alex" uniqKey="Wodak A" first="Alex" last="Wodak">Alex Wodak</name>
</author>
<author>
<name sortKey="Mcleod, Leah" sort="Mcleod, Leah" uniqKey="Mcleod L" first="Leah" last="Mcleod">Leah Mcleod</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">18641473</idno>
<idno type="pmc">3329723</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329723</idno>
<idno type="RBID">PMC:3329723</idno>
<idno type="doi">10.1097/01.aids.0000327439.20914.33</idno>
<date when="2008">2008</date>
<idno type="wicri:Area/Pmc/Corpus">001D36</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001D36</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">The role of harm reduction in controlling HIV among injecting drug users</title>
<author>
<name sortKey="Wodak, Alex" sort="Wodak, Alex" uniqKey="Wodak A" first="Alex" last="Wodak">Alex Wodak</name>
</author>
<author>
<name sortKey="Mcleod, Leah" sort="Mcleod, Leah" uniqKey="Mcleod L" first="Leah" last="Mcleod">Leah Mcleod</name>
</author>
</analytic>
<series>
<title level="j">AIDS (London, England)</title>
<idno type="ISSN">0269-9370</idno>
<idno type="eISSN">1473-5571</idno>
<imprint>
<date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="P1">Injecting drug users (IDU) now account for one in 10 new HIV infections world wide. Yet it has been known since the early 1990s that HIV among IDU can be effectively, safely and cost-effectively controlled by the early and vigorous implementation of a comprehensive package of strategies known as ’harm reduction’. This concept means that decreasing drug-related harms is accorded an even higher priority than reduction of drug consumption. Strategies required involve: explicit and peer-based education about the risk of HIV from sharing injecting equipment; needle syringe programmes; drug treatment (including especially opiate substitution treatment) and community development. Many countries experiencing or threatened by an HIV epidemic among IDU have now adopted harm reduction but often implementation has been too little and too late. Although coverage is slowly improving in many countries, HIV is still spreading faster among IDU than harm reduction programmes while coverage in correctional centres lags far behind community settings. The scientific debate about harm reduction is now over. National and international support for harm reduction is growing while almost all the major UN organizations responsible for drug policy now support harm reduction. Only a small number of countries, led by the USA, are still vehemently opposed to harm reduction. Excessive reliance on drug law enforcement remains the major barrier to increased adoption of harm reduction. Sometimes zealous drug law enforcement undermines harm reduction. A more balanced approach to drug law enforcement is required with illicit drug use recognized primarily as a health and social problem.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8710219</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1493</journal-id>
<journal-id journal-id-type="nlm-ta">AIDS</journal-id>
<journal-id journal-id-type="iso-abbrev">AIDS</journal-id>
<journal-title-group>
<journal-title>AIDS (London, England)</journal-title>
</journal-title-group>
<issn pub-type="ppub">0269-9370</issn>
<issn pub-type="epub">1473-5571</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">18641473</article-id>
<article-id pub-id-type="pmc">3329723</article-id>
<article-id pub-id-type="doi">10.1097/01.aids.0000327439.20914.33</article-id>
<article-id pub-id-type="manuscript">NIHMS313886</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The role of harm reduction in controlling HIV among injecting drug users</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wodak</surname>
<given-names>Alex</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McLeod</surname>
<given-names>Leah</given-names>
</name>
</contrib>
<aff id="A1">Alcohol and Drug Service, St Vincent’s Hospital, Darlinghurst, New South Wales, Australia</aff>
</contrib-group>
<author-notes>
<corresp id="CR1">Correspondence to Alex Wodak, Alcohol and Drug Service, St Vincent’s Hospital, Darlinghurst, NSW 2010, Australia. </corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>26</day>
<month>3</month>
<year>2012</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>19</day>
<month>4</month>
<year>2012</year>
</pub-date>
<volume>22</volume>
<issue>Suppl 2</issue>
<fpage>S81</fpage>
<lpage>S92</lpage>
<permissions>
<copyright-statement>© 2008 Wolters Kluwer Health | Lippincott Williams & Wilkins</copyright-statement>
<copyright-year>2008</copyright-year>
</permissions>
<abstract>
<p id="P1">Injecting drug users (IDU) now account for one in 10 new HIV infections world wide. Yet it has been known since the early 1990s that HIV among IDU can be effectively, safely and cost-effectively controlled by the early and vigorous implementation of a comprehensive package of strategies known as ’harm reduction’. This concept means that decreasing drug-related harms is accorded an even higher priority than reduction of drug consumption. Strategies required involve: explicit and peer-based education about the risk of HIV from sharing injecting equipment; needle syringe programmes; drug treatment (including especially opiate substitution treatment) and community development. Many countries experiencing or threatened by an HIV epidemic among IDU have now adopted harm reduction but often implementation has been too little and too late. Although coverage is slowly improving in many countries, HIV is still spreading faster among IDU than harm reduction programmes while coverage in correctional centres lags far behind community settings. The scientific debate about harm reduction is now over. National and international support for harm reduction is growing while almost all the major UN organizations responsible for drug policy now support harm reduction. Only a small number of countries, led by the USA, are still vehemently opposed to harm reduction. Excessive reliance on drug law enforcement remains the major barrier to increased adoption of harm reduction. Sometimes zealous drug law enforcement undermines harm reduction. A more balanced approach to drug law enforcement is required with illicit drug use recognized primarily as a health and social problem.</p>
</abstract>
<kwd-group>
<kwd>controlling HIV</kwd>
<kwd>drug law reform</kwd>
<kwd>harm reduction</kwd>
<kwd>human rights</kwd>
<kwd>IDU</kwd>
<kwd>methadone</kwd>
<kwd>needle syringe programmes</kwd>
<kwd>pharmacotherapy</kwd>
<kwd>war against drugs</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source country="United States">National Institute of Mental Health : NIMH</funding-source>
<award-id>P30 MH058107-11 || MH</award-id>
</award-group>
<award-group>
<funding-source country="United States">National Institute of Mental Health : NIMH</funding-source>
<award-id>P30 MH043520-15A1 || MH</award-id>
</award-group>
<award-group>
<funding-source country="United States">National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID</funding-source>
<award-id>P30 AI028697-19 || AI</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D36  | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 001D36  | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     
   |texte=   
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024